NEAL BARSHES to Cost-Benefit Analysis
This is a "connection" page, showing publications NEAL BARSHES has written about Cost-Benefit Analysis.
Connection Strength
0.751
-
A model to estimate cost-savings in diabetic foot ulcer prevention efforts. J Diabetes Complications. 2017 Apr; 31(4):700-707.
Score: 0.115
-
The accuracy and cost-effectiveness of strategies used to identify peripheral artery disease among patients with diabetic foot ulcers. J Vasc Surg. 2016 Dec; 64(6):1682-1690.e3.
Score: 0.112
-
Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease. J Vasc Surg. 2014 Aug; 60(2):369-374.e1.
Score: 0.095
-
Cost-effectiveness of revascularization for limb preservation in patients with marginal functional status. Ann Vasc Surg. 2014 Jan; 28(1):10-7.
Score: 0.093
-
A cost-effectiveness analysis of infrainguinal bypass in?the absence of great saphenous vein conduit. J Vasc Surg. 2013 Jun; 57(6):1466-70.
Score: 0.088
-
Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg. 2012 Oct; 56(4):1015-24.e1.
Score: 0.085
-
A primer on cost-effectiveness analyses for vascular surgeons. J Vasc Surg. 2012 Jun; 55(6):1794-800.
Score: 0.084
-
A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg. 2011 Oct; 213(4):552-66.e5.
Score: 0.080